I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Telmisartan versus metformin in downregulating myostatin ge..:
Ahmed Abd-Eltawab Tammam
;
Waleed Y. Rizg
;
Amy Fakhry Boushra
...
https://www.frontiersin.org/articles/10.3389/fphar.2023.1228525/full. , 2023
Link:
https://doi.org/10.3389/fphar.2023.1228525
RT Journal T1
Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:fc0f529f083d40bbb69bbf6715205986&Exemplar=1&LAN=DE A1 Ahmed Abd-Eltawab Tammam A1 Waleed Y. Rizg A1 Amy Fakhry Boushra A1 Maha Alhelf A1 Mohammed Alissa A1 Ghada F. Soliman A1 Ghada Nady Ouais A1 Khaled M. Hosny A1 Hala M. Alkhalidi A1 Ahmed Magdy Elebiary PB Frontiers Media S.A. YR 2023 K1 antidiabetic drugs K1 insulin resistance K1 metformin K1 myostatin K1 telmisartan K1 type 2 DM K1 Therapeutics. Pharmacology K1 RM1-950 JF https://www.frontiersin.org/articles/10.3389/fphar.2023.1228525/full LK http://dx.doi.org/https://doi.org/10.3389/fphar.2023.1228525 DO https://doi.org/10.3389/fphar.2023.1228525 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)